Home Use of Oxygen in Approved Clinical Trials | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for home use of oxygen in approved clinical trials, effective May 15, 2026. Here's what billing teams need to do.

CMS home oxygen coverage has always had firm guardrails. This modification specifically addresses oxygen furnished in the home setting as part of approved clinical trials — a narrow but financially meaningful category for DME suppliers and practices with active research programs. The policy does not list specific CPT or HCPCS codes in the available data, but home oxygen billing typically runs through HCPCS codes in the E0400–E1406 range. If your billing team handles oxygen reimbursement for any Medicare patients enrolled in clinical trials, this change is on your radar before May 15, 2026.

Quick-Reference Table

CMS Home Oxygen Clinical Trial Coverage Criteria and Medical Necessity Requirements 2026

The core question this policy answers is straightforward: when does Medicare cover home oxygen for a patient enrolled in a clinical trial?

The answer sits at the intersection of two coverage frameworks. First, Medicare's standard home oxygen coverage policy requires documented medical necessity — typically a qualifying blood gas study or oxygen saturation test showing hypoxemia. Second, the Medicare clinical trial policy governs which trial-related items and services CMS will pay for. This modification addresses what happens when both frameworks apply at once.

For CMS home oxygen clinical trial coverage to apply, the trial must meet the definition of an "approved" clinical trial under Medicare rules. CMS uses a specific definition here. The trial must be funded by a qualifying government agency, conducted under an IND application reviewed by the FDA, or approved by a qualifying institutional review board. Not every study with IRB approval qualifies. This distinction matters enormously at the claim level — a denial for "non-covered clinical trial" is avoidable if your team verifies trial eligibility before billing.

Medical necessity for the oxygen itself still has to be established independently. The patient's clinical condition drives coverage, not trial enrollment alone. If the underlying oxygen need doesn't meet Medicare's standard qualifying criteria, trial enrollment doesn't change that. You need both: an approved trial and a medically necessary oxygen need.

Prior authorization requirements for home oxygen under Medicare depend on the durable medical equipment Medicare Administrative Contractor jurisdiction. Check with your MAC before assuming a particular trial-based claim will process cleanly. Some MACs have issued local coverage determinations that add criteria on top of the national framework.

CMS Home Oxygen Clinical Trial Exclusions and Non-Covered Indications

This is where the policy gets specific — and where claim denial risk concentrates.

Oxygen furnished as part of a clinical trial is not automatically covered just because the trial is approved. CMS distinguishes between routine costs of trial participation and costs that would otherwise be covered outside the trial. If the home oxygen would be covered for the patient under ordinary circumstances — meaning they meet standard medical necessity criteria — CMS covers it. If the oxygen is being provided solely because the trial protocol requires it and the patient wouldn't otherwise qualify, it's a different story.

The policy also does not extend coverage to oxygen provided in settings other than the home. Hospital-based oxygen, even if the same patient is enrolled in the same trial, falls under different coverage rules. Home use is the operative term in this coverage policy.

Investigational use of oxygen delivery methods — meaning novel concentrators, delivery systems, or protocols being tested as the intervention itself — also falls outside standard coverage. If the trial is studying an oxygen therapy modality, the oxygen may be the experimental item, not the routine cost. That distinction needs to run through your compliance officer or billing consultant before you submit a claim.

Coverage Indications at a Glance

CMS Home Oxygen Clinical Trial Billing Guidelines and Action Items 2026

Home oxygen billing for clinical trial patients is an area where documentation gaps cause most denials. Here's what to do before May 15, 2026.

CPT, HCPCS, and ICD-10 Codes for Home Use of Oxygen in Clinical Trials Under This Policy

The policy data for this modification does not list specific CPT, HCPCS, or ICD-10 codes. Do not infer covered codes from this document alone.

That said, home oxygen billing under Medicare runs through established HCPCS codes. Your coding team should already have these in charge capture — what changes with this policy is the coverage criteria framework that governs when those codes are payable for clinical trial patients. Work with your coding team and compliance officer to map your existing home oxygen codes to the updated coverage logic before May 15, 2026.

A Note on Code Selection

Because this policy involves clinical trial billing, the presence of a clinical trial modifier — specifically modifier Q0, Q1, or the appropriate research billing modifier per your MAC's instructions — may be relevant to how you report these claims. Modifier usage for clinical trial claims is its own area of complexity. If your team doesn't have a documented protocol for clinical trial claim submission under Medicare, build one now. A mismatch between the clinical trial status on the claim and the oxygen coverage documentation is a reliable path to a claim denial.